Prolyl-hydroxylase inhibition and HIF activation in osteoblasts promotes an adipocytic phenotype

Authors

  • R. Irwin,

    1. Departments of Physiology and Radiology, Biomedical Imaging Research Center, Michigan State University, East Lansing, Michigan 48824
    Search for more papers by this author
  • J.J. LaPres,

    1. Department of Biochemistry, Biomedical Imaging Center, Michigan State University, East Lansing, Michigan 48824
    Search for more papers by this author
  • S. Kinser,

    1. Departments of Physiology and Radiology, Biomedical Imaging Research Center, Michigan State University, East Lansing, Michigan 48824
    Search for more papers by this author
  • L.R. McCabe

    Corresponding author
    1. Departments of Physiology and Radiology, Biomedical Imaging Research Center, Michigan State University, East Lansing, Michigan 48824
    • Departments of Physiology and Radiology, Michigan State University, Biomedical Imaging Research Center, 2201 Biomedical & Physical Sciences Building, East Lansing, MI 48824.
    Search for more papers by this author

Abstract

Bone is a dynamic environment where cells sense and adapt to changes in nutrient and oxygen availability. Conditions associated with hypoxia in bone are also associated with bone loss. In vitro hypoxia (2% oxygen) alters gene expression in osteoblasts and osteocytes and induces cellular changes including the upregulation of hypoxia inducible factor (HIF) levels. Our studies show that osteoblasts respond to hypoxia (2% oxygen) by enhancing expression of genes associated with adipocyte/lipogenesis phenotype (C/EBPβ, PPARγ2, and aP2) and by suppressing expression of genes associated with osteoblast differentiation (alkaline phosphatase, AP). Hypoxia increased HIF protein levels, hypoxic response element (HRE) binding, and HRE-reporter activity. We also demonstrate that prolyl-hydroxylases 2 and 3 (PHD2, PHD3), one of the major factors coordinating HIF degradation under normoxic but not hypoxic conditions, are induced in osteoblasts under hypoxic conditions. To further determine the contribution of PHDs and upregulated HIF activity in modulating osteoblast phenotype, we treated osteoblasts with a PHD inhibitor, dimethyloxaloylglycine (DMOG), and maintained cells under normoxic conditions. Similar to hypoxic conditions, HRE reporter activity was increased and adipogenic gene expression was increased while osteoblastic genes were suppressed. Taken together, our findings indicate a role for PHDs and HIFs in the regulation of osteoblast phenotype. J. Cell. Biochem. 100: 762–772, 2007. © 2006 Wiley-Liss, Inc.

Ancillary